“U.S. business was driven by strong volume growth and new launches. In U.S. Branded, we are encouraged by the traction building across our existing portfolio,” said
Source: The Hindu Business (English)
Alembic Pharma Q2 net surges 81% to ₹335 crore
Read full article on The Hindu Business (English)
Related News
Automation has boosted employment, hiring of low-skilled workers in India, says ABB chief
Adani Ports to acquire Europe’s Evos for €2.56 billion EV
Markets surge for sixth day; Sensex jumps 2,009 points
Rupee settles flat at 94.46 against U.S. dollar
ബെംഗളൂരുവിൽ യെല്ലോ അലർട്ട്; കനത്ത മഴയും വെള്ളക്കെട്ടും വരുന്നു, യാത്രക്കാർക്ക് ജാഗ്രതാ നിർദ്ദേശം
Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue
